Ascendis Pharma A/S (ASND)
Nasdaq: ASND · Pharmaceutical Preparations · filing with the SEC since 2014
The company now
Ascendis Pharma A/S is classed by the SEC under Pharmaceutical Preparations (industry code 2834). In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of EUR 720 million and a loss of EUR 228 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.